GSK Medical and Scientific Director, Barbara Grassi, illustrates the great effort of the British pharmaceutical company in this innovation in the treatment of multiple myeloma. A conjugated antibody that, thanks to its specific function, is able to conduct a chemotherapy drug with a localized action that treats the pathology and limits the side effects.
#BelaMaf #Barbara #Grassi #Maximum #expression #precision #medicine